DSM-Firmenich and ExoLab Italia have recently announced a strategic partnership aimed at developing innovative plant-derived exosomal technologies for the beauty industry. This collaboration aligns with DSM-Firmenich’s commitment to providing high-quality products that meet the growing demand for natural, effective, and sustainable ingredients in skincare.
According to Emmanuel Butstraen, president of perfumery and beauty at DSM-Firmenich, this partnership is a significant step towards achieving the company’s overall strategy for innovation and sustained growth. “We are excited to be working with ExoLab Italia, which shares our dedication to using natural ingredients in skincare products,” he said.
Exosomes are extracellular vesicles naturally released by cells in all living organisms. They act as a natural delivery system for molecules produced by cells and facilitate intercellular communication. Plant-derived exosomes have numerous benefits for personal care and beauty products, including enhancing skin health and combating signs of aging. They are packed with antioxidants, vitamins, proteins, lipids, and messenger molecules that work together to improve skin health.
ExoLab Italia is known for its expertise in exosomal technologies and is focused on advancing nutraceutical supplements, cosmetic products, and healthcare solutions. With a focus on plant-derived exosomes, ExoLab Italia offers unique scientific proficiency in cellular health and skin recovery. This combined with DSM-Firmenich’s expertise in skin biology, claim substantiation, and active ingredients has the potential to raise the standards of natural and effective skincare to unprecedented levels according to Gabriele Campi CEO of ExoLab Italia.
.jpg?height=635&t=1714449889&width=1200)